✦ LIBER ✦

Pharmacological postconditioning by bolus injection of phosphodiesterase-5 inhibitors vardenafil and sildenafil

✍ Scribed by Bernd Ebner, Annette Ebner, Anna Reetz…

Book ID: 120748586
Publisher: Springer
Year: 2013
Tongue: English
Weight: 339 KB
Volume: 379
Category: Article
ISSN: 0300-8177
DOI: 10.1007/s11010-013-1625-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential Effects of the Phosphodiest

Differential Effects of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Vardenafil, and Tadalafil in Rat Aorta

✍ Teixeira, C. E. 📂 Article 📅 2005 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 521 KB

EFFECT OF THE PHOSPHODIESTERASE 5 INHIBI

EFFECT OF THE PHOSPHODIESTERASE 5 INHIBITORS SILDENAFIL, TADALAFIL AND VARDENAFIL ON RAT ANOCOCCYGEUS MUSCLE: FUNCTIONAL AND BIOCHEMICAL ASPECTS

✍ Haroldo A Toque; Fernanda BM Priviero; Saiprasad M Zemse; Edson Antunes; Cleber 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

Sildenafil and vardenafil, types 5 and 6

Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells

✍ Sarfati, M. 📂 Article 📅 2003 🏛 American Society of Hematology 🌐 English ⚖ 223 KB

The Contributions of Cytochromes P450 3A

The Contributions of Cytochromes P450 3A4 and 3A5 to the Metabolism of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Udenafil, and Vardenafil

✍ Ku, H.-Y.; Ahn, H.-J.; Seo, K.-A.; Kim, H.; Oh, M.; Bae, S. K.; Shin, J.-G.; Sho 📂 Article 📅 2008 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 233 KB

Absence of clinically important HERG cha

Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5—sildenafil, tadalafil, and vardenafil

✍ R. Dustan Sarazan; William J. Crumb Jr.; Charles M. Beasley Jr.; Jeffrey T. Emmi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Use of combined intracorporal injection

Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy

✍ Jack H. Mydlo; Rosalia Viterbo; Paul Crispen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB